MX9805499A - Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso. - Google Patents

Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso.

Info

Publication number
MX9805499A
MX9805499A MX9805499A MX9805499A MX9805499A MX 9805499 A MX9805499 A MX 9805499A MX 9805499 A MX9805499 A MX 9805499A MX 9805499 A MX9805499 A MX 9805499A MX 9805499 A MX9805499 A MX 9805499A
Authority
MX
Mexico
Prior art keywords
diazacycloheptane
compounds
cyclooctane
substituted aza
aza
Prior art date
Application number
MX9805499A
Other languages
English (en)
Spanish (es)
Inventor
Hans-Joerg Treiber
Stefan Blank
Dorothea Starck
Liliane Unger
Hans-Juergen Teschendorf
Karsten Wicke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of MX9805499A publication Critical patent/MX9805499A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
MX9805499A 1996-01-12 1998-07-07 Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso. MX9805499A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19600934A DE19600934A1 (de) 1996-01-12 1996-01-12 Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung

Publications (1)

Publication Number Publication Date
MX9805499A true MX9805499A (es) 1998-11-30

Family

ID=7782613

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9805499A MX9805499A (es) 1996-01-12 1998-07-07 Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso.

Country Status (26)

Country Link
US (2) US6214822B1 (enExample)
EP (1) EP0877744B1 (enExample)
JP (1) JP4349657B2 (enExample)
KR (1) KR100441073B1 (enExample)
CN (2) CN1075070C (enExample)
AR (1) AR005868A1 (enExample)
AT (1) ATE273301T1 (enExample)
AU (1) AU717726B2 (enExample)
BG (1) BG64098B1 (enExample)
CA (1) CA2241787C (enExample)
CO (1) CO4790173A1 (enExample)
CZ (1) CZ297981B6 (enExample)
DE (2) DE19600934A1 (enExample)
ES (1) ES2225947T3 (enExample)
HR (1) HRP970021A2 (enExample)
HU (1) HU228457B1 (enExample)
IL (1) IL125076A (enExample)
MX (1) MX9805499A (enExample)
NO (1) NO316753B1 (enExample)
NZ (1) NZ326332A (enExample)
PL (1) PL327692A1 (enExample)
SK (1) SK284987B6 (enExample)
TR (1) TR199801302T2 (enExample)
TW (1) TW475929B (enExample)
WO (1) WO1997025324A1 (enExample)
ZA (1) ZA97209B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19728996A1 (de) * 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
PE20001088A1 (es) 1998-10-08 2000-12-02 Smithkline Beecham Plc Compuestos derivados de tetrahidrobenzazepina
AR022228A1 (es) * 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para la preparar dicha composicion
DE19922443A1 (de) * 1999-05-07 2000-11-09 Basf Ag Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
US7037916B2 (en) 1999-07-15 2006-05-02 Pharmacopeia Drug Discovery, Inc. Pyrimidine derivatives as IL-8 receptor antagonists
US20030087917A1 (en) * 2000-03-27 2003-05-08 Dorothea Strack Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system
EP1632483B1 (en) 2001-02-16 2008-10-29 Aventis Pharmaceuticals Inc. Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
DE10109866A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
DE10131543A1 (de) * 2001-06-29 2003-01-16 Abbott Lab Pyrimidinoxyalkylpiperazine und ihre therapeutische Verwendung
AU2002361345B8 (en) * 2001-11-28 2008-06-26 Ipsen Pharma S.A.S. 5-sulphanyl-4H-1,2,4-triazole derivatives and their use as medicine
EP1484971B1 (en) * 2002-03-15 2007-07-04 Ciba SC Holding AG Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces
DE10304870A1 (de) * 2003-02-06 2004-08-19 Abbott Gmbh & Co. Kg Triazolverbindungen und ihre therapeutische Verwendung
TW200507841A (en) * 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
DE10358004A1 (de) * 2003-12-11 2005-07-14 Abbott Gmbh & Co. Kg Ketolactam-Verbindungen und ihre Verwendung
DE102004027358A1 (de) 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
FR2877005A1 (fr) * 2004-10-22 2006-04-28 Bioprojet Soc Civ Ile Nouveaux derives d'arylpiperazine
WO2006081289A2 (en) * 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
JP2007106746A (ja) * 2005-09-13 2007-04-26 Tosoh Corp 新規アリールホモピペラジン類、またはその塩と製造方法
US7935706B2 (en) * 2006-02-23 2011-05-03 Shionogi & Co., Ltd. Nitrogen-containing heterocycle derivatives substituted with cyclic group
US20070293548A1 (en) * 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
EP1882688A1 (en) * 2006-07-25 2008-01-30 EPFL Ecole Polytechnique Fédérale de Lausanne Labelling of fusion proteins with synthetic probes
JP4840440B2 (ja) * 2008-12-24 2011-12-21 ソニー株式会社 画像処理装置およびその方法、並びにプログラム
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
WO2011091153A1 (en) * 2010-01-25 2011-07-28 Chdi, Inc. Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
WO2012003418A2 (en) * 2010-07-02 2012-01-05 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine d2 receptors
NZ610315A (en) 2010-11-15 2015-08-28 Univ Leuven Kath Antiviral condensed heterocyclic compounds
EA027451B1 (ru) 2011-08-30 2017-07-31 Схди Фаундейшн, Инк. Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и их применение
SG2014011654A (en) 2011-08-30 2014-08-28 Chdi Foundation Inc Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
EP3087051B1 (en) 2013-12-24 2020-07-15 Oncotartis Inc. Benzamide and nicotinamide compounds and methods of using same
CN114588157A (zh) 2014-07-17 2022-06-07 Chdi基金会股份有限公司 用于治疗hiv相关病症的方法和组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE628766A (enExample) 1962-12-26
BE792206A (enExample) 1971-12-02 1973-06-01 Byk Gulden Lomberg Chem Fab
US5139998A (en) 1988-08-31 1992-08-18 Superconductor Technologies, Inc. Controlled thallous oxide evaporation for thallium superconductor films and reactor design
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
US5008267A (en) 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JP2815218B2 (ja) 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
FR2663638B2 (fr) 1990-04-06 1995-02-10 Institut Nal Sante Recherc Medic Polypeptides ayant une activite de recepteur dopaminergique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
JP2518965B2 (ja) 1990-09-21 1996-07-31 三井東圧化学株式会社 新規ピリジン誘導体及びそれを有効成分として含有する制癌剤効果増強剤
FR2668771B1 (fr) 1990-11-06 1995-03-17 Inst Nat Sante Rech Med Acides nucleiques codant pour des polypeptides ayant une activite de recepteur dopaminergique humain et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
DE4425144A1 (de) 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
DE4425146A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
DE4425143A1 (de) 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
DE4425145A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung von Thiazol- und Thiadiazolverbindungen
US5635503A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Company Dihydropyridine npy antagonists: piperazine derivatives
FR2742149B1 (fr) 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques

Also Published As

Publication number Publication date
CN1075070C (zh) 2001-11-21
IL125076A0 (en) 1999-01-26
JP4349657B2 (ja) 2009-10-21
US6214822B1 (en) 2001-04-10
HUP9901590A3 (en) 2002-01-28
AU1440797A (en) 1997-08-01
CZ215998A3 (cs) 1999-05-12
AR005868A1 (es) 1999-07-21
IL125076A (en) 2001-05-20
TW475929B (en) 2002-02-11
US6352981B1 (en) 2002-03-05
JP2000505072A (ja) 2000-04-25
TR199801302T2 (xx) 1998-11-23
NO316753B1 (no) 2004-04-26
CN1146551C (zh) 2004-04-21
DE59711847D1 (de) 2004-09-16
EP0877744A1 (de) 1998-11-18
CA2241787A1 (en) 1997-07-17
WO1997025324A1 (de) 1997-07-17
BG102616A (en) 1999-04-30
ATE273301T1 (de) 2004-08-15
EP0877744B1 (de) 2004-08-11
ES2225947T3 (es) 2005-03-16
DE19600934A1 (de) 1997-07-17
SK94198A3 (en) 1999-03-12
CN1212692A (zh) 1999-03-31
HRP970021A2 (en) 1998-04-30
SK284987B6 (sk) 2006-04-06
NO983187L (no) 1998-09-09
KR100441073B1 (ko) 2004-11-16
HUP9901590A2 (hu) 1999-08-30
NZ326332A (en) 1999-04-29
HU228457B1 (en) 2013-03-28
CN1348956A (zh) 2002-05-15
BG64098B1 (bg) 2003-12-31
CA2241787C (en) 2006-04-04
CZ297981B6 (cs) 2007-05-16
CO4790173A1 (es) 1999-05-31
AU717726B2 (en) 2000-03-30
PL327692A1 (en) 1998-12-21
ZA97209B (en) 1998-07-10
KR19990077127A (ko) 1999-10-25

Similar Documents

Publication Publication Date Title
MX9805499A (es) Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso.
MX9700430A (es) El uso de compuestos heterociclicos.
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
TR200000009T2 (tr) Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları.
TR200200068T2 (tr) Nematisital triflüorobütenler
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
MY120511A (en) New pesticides
GR3032161T3 (en) Amido siladiyl bridged catalyst components, methods of making and using
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
NO970162L (no) Substituerte pyrimidinforbindelser og anvendelse derav
CA2276455A1 (en) Phthalazinones
MX9603465A (es) N-pirazolilanilinas y n-pirazolilaminopiridinas como agentes pesticidas.
MXPA04004939A (es) 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion.
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
TR199901282T2 (xx) Heterosiklik olarak ikame edilmi� yeni benzamitler.
MX9801190A (es) Inhibidores de prolil endopeptidasa.
MY124078A (en) Eletriptan hydrobromide monohydrate
ES8500225A1 (es) Un procedimiento para preparar 3-fenoxi-1-azetidincarbo-xznmidas
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
ID27440A (id) Proses untuk menyiapkan penengah-penengah
PE20399A1 (es) Muteina ob
ZA983231B (en) Substituted benzyloxyimino compounds.
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
CA1263656C (en) ARYLOXYCYCLOALCANOLAMINOALCOYLENE-ARYL-KETONES